documents: FDA-2011-N-0898-0002
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | agency_id | docket_id | title | document_type | subtype | posted_date | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2011-N-0898-0002 | FDA | FDA-2011-N-0898 | OMB Changes - CDER2011187 Applications for Food and Drug Administration Approval to Market a New Drug: Revision of Postmarketing Reporting Requirements - Discontinuance; Interim final rule; request for comments, dated February 24, 2012 | Other | Memo | 2012-02-28T05:00:00Z | 2012 | 2 | 2012-02-28T05:00:00Z | 2012-02-28T13:15:53Z | 0 | 0 | 0900006480fc48e2 |
Links from other tables
- 0 rows from regs_document_id in fr_regs_crossref